dolphinium
commited on
Commit
·
4a63df8
1
Parent(s):
bbcff60
format document
Browse files- solr_metadata.py +711 -706
solr_metadata.py
CHANGED
@@ -161,7 +161,7 @@ field_metadata = [
|
|
161 |
"example_values": [50, 120.5, 176.157, 1000],
|
162 |
"definition": "The total value of a financial deal, in millions of USD. This is the primary numeric field for financial aggregations (sum, avg, etc.). To use this, you must also filter for news that has a deal value, e.g., 'total_deal_value_in_million:[0 TO *]'."
|
163 |
},
|
164 |
-
|
165 |
# NEW 'deal' CORE METADATA
|
166 |
{
|
167 |
"core_name": "deal",
|
@@ -370,7 +370,8 @@ field_metadata = [
|
|
370 |
"core_name": "compound",
|
371 |
"field_name": "molecule_id",
|
372 |
"type": "string",
|
373 |
-
|
|
|
374 |
"definition": "Unique identifier for the molecule associated with the compound."
|
375 |
},
|
376 |
{
|
@@ -447,7 +448,8 @@ field_metadata = [
|
|
447 |
"core_name": "compound",
|
448 |
"field_name": "owner_company_name",
|
449 |
"type": "string (multi-valued, exact match, for faceting)",
|
450 |
-
|
|
|
451 |
"definition": "The canonical, standardized name(s) of the owner company of the compound. Use for faceting on owner companies."
|
452 |
},
|
453 |
{
|
@@ -496,14 +498,16 @@ field_metadata = [
|
|
496 |
"core_name": "compound",
|
497 |
"field_name": "mechanism",
|
498 |
"type": "string (multi-valued, specific, for faceting)",
|
499 |
-
|
|
|
500 |
"definition": "The specific mechanism of action of the compound. Use for very specific mechanism queries or faceting."
|
501 |
},
|
502 |
{
|
503 |
"core_name": "compound",
|
504 |
"field_name": "mechanism_s",
|
505 |
"type": "string (multi-valued, for searching)",
|
506 |
-
|
|
|
507 |
"definition": "Broader, multi-valued mechanisms of action and their synonyms. **Use this field for broad mechanism searches** in the `query` parameter."
|
508 |
},
|
509 |
{
|
@@ -607,7 +611,8 @@ field_metadata = [
|
|
607 |
{
|
608 |
"core_name": "compound",
|
609 |
"field_name": "is_orphan",
|
610 |
-
|
|
|
611 |
"example_values": ["yes", "no"],
|
612 |
"definition": "Indicates if the compound has received orphan drug designation. Orphan drugs are intended for rare diseases that affect a small population, making them less profitable to develop without incentives. [2, 4, 7, 9, 10]"
|
613 |
},
|
@@ -640,706 +645,706 @@ field_metadata = [
|
|
640 |
"definition": "The logarithm of the octanol-water partition coefficient, a measure of a compound's lipophilicity (fat-liking) or hydrophilicity (water-liking). Higher values indicate more lipophilicity. [1, 3, 5, 6, 8]"
|
641 |
},
|
642 |
{
|
643 |
-
|
644 |
-
|
645 |
-
|
646 |
-
|
647 |
-
|
648 |
-
|
649 |
-
|
650 |
-
|
651 |
-
|
652 |
-
|
653 |
-
|
654 |
-
|
655 |
-
|
656 |
-
|
657 |
-
|
658 |
-
|
659 |
-
|
660 |
-
|
661 |
-
|
662 |
-
|
663 |
-
|
664 |
-
|
665 |
-
|
666 |
-
|
667 |
-
|
668 |
-
|
669 |
-
|
670 |
-
|
671 |
-
|
672 |
-
|
673 |
-
|
674 |
-
|
675 |
-
|
676 |
-
|
677 |
-
|
678 |
-
|
679 |
-
|
680 |
-
|
681 |
-
|
682 |
-
|
683 |
-
|
684 |
-
|
685 |
-
|
686 |
-
|
687 |
-
|
688 |
-
|
689 |
-
|
690 |
-
|
691 |
-
|
692 |
-
|
693 |
-
|
694 |
-
|
695 |
-
|
696 |
-
|
697 |
-
|
698 |
-
|
699 |
-
|
700 |
-
|
701 |
-
|
702 |
-
|
703 |
-
|
704 |
-
|
705 |
-
|
706 |
-
|
707 |
-
|
708 |
-
|
709 |
-
|
710 |
-
|
711 |
-
|
712 |
-
|
713 |
-
|
714 |
-
|
715 |
-
|
716 |
-
|
717 |
-
|
718 |
-
|
719 |
-
|
720 |
-
|
721 |
-
|
722 |
-
|
723 |
-
|
724 |
-
|
725 |
-
|
726 |
-
|
727 |
-
|
728 |
-
|
729 |
-
|
730 |
-
|
731 |
-
|
732 |
-
|
733 |
-
|
734 |
-
|
735 |
-
|
736 |
-
|
737 |
-
|
738 |
-
|
739 |
-
|
740 |
-
|
741 |
-
|
742 |
-
|
743 |
-
|
744 |
-
|
745 |
-
|
746 |
-
|
747 |
-
|
748 |
-
|
749 |
-
|
750 |
-
|
751 |
-
|
752 |
-
|
753 |
-
|
754 |
-
|
755 |
-
|
756 |
-
|
757 |
-
|
758 |
-
|
759 |
-
|
760 |
-
|
761 |
-
|
762 |
-
|
763 |
-
|
764 |
-
|
765 |
-
|
766 |
-
|
767 |
-
|
768 |
-
|
769 |
-
|
770 |
-
|
771 |
-
|
772 |
-
|
773 |
-
|
774 |
-
|
775 |
-
|
776 |
-
|
777 |
-
|
778 |
-
|
779 |
-
|
780 |
-
|
781 |
-
|
782 |
-
|
783 |
-
|
784 |
-
|
785 |
-
|
786 |
-
|
787 |
-
|
788 |
-
|
789 |
-
|
790 |
-
|
791 |
-
|
792 |
-
|
793 |
-
|
794 |
-
|
795 |
-
|
796 |
-
|
797 |
-
|
798 |
-
|
799 |
-
|
800 |
-
|
801 |
-
|
802 |
-
|
803 |
-
|
804 |
-
|
805 |
-
|
806 |
-
|
807 |
-
|
808 |
-
|
809 |
-
|
810 |
-
|
811 |
-
|
812 |
-
|
813 |
-
|
814 |
-
|
815 |
-
|
816 |
-
|
817 |
-
|
818 |
-
|
819 |
-
|
820 |
-
|
821 |
-
|
822 |
-
|
823 |
-
|
824 |
-
|
825 |
-
|
826 |
-
|
827 |
-
|
828 |
-
|
829 |
-
|
830 |
-
|
831 |
-
|
832 |
-
|
833 |
-
|
834 |
-
|
835 |
-
|
836 |
-
|
837 |
-
|
838 |
-
|
839 |
-
|
840 |
-
|
841 |
-
|
842 |
-
|
843 |
-
|
844 |
-
|
845 |
-
|
846 |
-
|
847 |
-
|
848 |
-
|
849 |
-
|
850 |
-
|
851 |
-
|
852 |
-
|
853 |
-
|
854 |
-
|
855 |
-
|
856 |
-
|
857 |
-
|
858 |
-
|
859 |
-
|
860 |
-
|
861 |
-
|
862 |
-
|
863 |
-
|
864 |
-
|
865 |
-
|
866 |
-
|
867 |
-
|
868 |
-
|
869 |
-
|
870 |
-
|
871 |
-
|
872 |
-
|
873 |
-
|
874 |
-
|
875 |
-
|
876 |
-
|
877 |
-
|
878 |
-
|
879 |
-
|
880 |
-
|
881 |
-
|
882 |
-
|
883 |
-
|
884 |
-
|
885 |
-
|
886 |
-
|
887 |
-
|
888 |
-
|
889 |
-
|
890 |
-
|
891 |
-
|
892 |
-
|
893 |
-
|
894 |
-
|
895 |
-
|
896 |
-
|
897 |
-
|
898 |
-
|
899 |
-
|
900 |
-
|
901 |
-
|
902 |
-
|
903 |
-
|
904 |
-
|
905 |
-
|
906 |
-
|
907 |
-
|
908 |
-
|
909 |
-
|
910 |
-
|
911 |
-
|
912 |
-
|
913 |
-
|
914 |
-
|
915 |
-
|
916 |
-
|
917 |
-
|
918 |
-
|
919 |
-
|
920 |
-
|
921 |
-
|
922 |
-
|
923 |
-
|
924 |
-
|
925 |
-
|
926 |
-
|
927 |
-
|
928 |
-
|
929 |
-
|
930 |
-
|
931 |
-
|
932 |
-
|
933 |
-
|
934 |
-
|
935 |
-
|
936 |
-
|
937 |
-
|
938 |
-
|
939 |
-
|
940 |
-
|
941 |
-
|
942 |
-
|
943 |
-
|
944 |
-
|
945 |
-
|
946 |
-
|
947 |
-
|
948 |
-
|
949 |
-
|
950 |
-
|
951 |
-
|
952 |
-
|
953 |
-
|
954 |
-
|
955 |
-
|
956 |
-
|
957 |
-
|
958 |
-
|
959 |
-
|
960 |
-
|
961 |
-
|
962 |
-
|
963 |
-
|
964 |
-
|
965 |
-
|
966 |
-
|
967 |
-
|
968 |
-
|
969 |
-
|
970 |
-
|
971 |
-
|
972 |
-
|
973 |
-
|
974 |
-
|
975 |
-
|
976 |
-
|
977 |
-
|
978 |
-
|
979 |
-
|
980 |
-
|
981 |
-
|
982 |
-
|
983 |
-
|
984 |
-
|
985 |
-
|
986 |
-
|
987 |
-
|
988 |
-
|
989 |
-
|
990 |
-
|
991 |
-
|
992 |
-
|
993 |
-
|
994 |
-
|
995 |
-
|
996 |
-
|
997 |
-
|
998 |
-
|
999 |
-
|
1000 |
-
|
1001 |
-
|
1002 |
-
|
1003 |
-
|
1004 |
-
|
1005 |
-
|
1006 |
-
|
1007 |
-
|
1008 |
-
|
1009 |
-
|
1010 |
-
|
1011 |
-
|
1012 |
-
|
1013 |
-
|
1014 |
-
|
1015 |
-
|
1016 |
-
|
1017 |
-
|
1018 |
-
|
1019 |
-
|
1020 |
-
|
1021 |
-
|
1022 |
-
|
1023 |
-
|
1024 |
-
|
1025 |
-
|
1026 |
-
|
1027 |
-
|
1028 |
-
|
1029 |
-
|
1030 |
-
|
1031 |
-
|
1032 |
-
|
1033 |
-
|
1034 |
-
|
1035 |
-
|
1036 |
-
|
1037 |
-
|
1038 |
-
|
1039 |
-
|
1040 |
-
|
1041 |
-
|
1042 |
-
|
1043 |
-
|
1044 |
-
|
1045 |
-
|
1046 |
-
|
1047 |
-
|
1048 |
-
|
1049 |
-
|
1050 |
-
|
1051 |
-
|
1052 |
-
|
1053 |
-
|
1054 |
-
|
1055 |
-
|
1056 |
-
|
1057 |
-
|
1058 |
-
|
1059 |
-
|
1060 |
-
|
1061 |
-
|
1062 |
-
|
1063 |
-
|
1064 |
-
|
1065 |
-
|
1066 |
-
|
1067 |
-
|
1068 |
-
|
1069 |
-
|
1070 |
-
|
1071 |
-
|
1072 |
-
|
1073 |
-
|
1074 |
-
|
1075 |
-
|
1076 |
-
|
1077 |
-
|
1078 |
-
|
1079 |
-
|
1080 |
-
|
1081 |
-
|
1082 |
-
|
1083 |
-
|
1084 |
-
|
1085 |
-
|
1086 |
-
|
1087 |
-
|
1088 |
-
|
1089 |
-
|
1090 |
-
|
1091 |
-
|
1092 |
-
|
1093 |
-
|
1094 |
-
|
1095 |
-
|
1096 |
-
|
1097 |
-
|
1098 |
-
|
1099 |
-
|
1100 |
-
|
1101 |
-
|
1102 |
-
|
1103 |
-
|
1104 |
-
|
1105 |
-
|
1106 |
-
|
1107 |
-
|
1108 |
-
|
1109 |
-
|
1110 |
-
|
1111 |
-
|
1112 |
-
|
1113 |
-
|
1114 |
-
|
1115 |
-
|
1116 |
-
|
1117 |
-
|
1118 |
-
|
1119 |
-
|
1120 |
-
|
1121 |
-
|
1122 |
-
|
1123 |
-
|
1124 |
-
|
1125 |
-
|
1126 |
-
|
1127 |
-
|
1128 |
-
|
1129 |
-
|
1130 |
-
|
1131 |
-
|
1132 |
-
|
1133 |
-
|
1134 |
-
|
1135 |
-
|
1136 |
-
|
1137 |
-
|
1138 |
-
|
1139 |
-
|
1140 |
-
|
1141 |
-
|
1142 |
-
|
1143 |
-
|
1144 |
-
|
1145 |
-
|
1146 |
-
|
1147 |
-
|
1148 |
-
|
1149 |
-
|
1150 |
-
|
1151 |
-
|
1152 |
-
|
1153 |
-
|
1154 |
-
|
1155 |
-
|
1156 |
-
|
1157 |
-
|
1158 |
-
|
1159 |
-
|
1160 |
-
|
1161 |
-
|
1162 |
-
|
1163 |
-
|
1164 |
-
|
1165 |
-
|
1166 |
-
|
1167 |
-
|
1168 |
-
|
1169 |
-
|
1170 |
-
|
1171 |
-
|
1172 |
-
|
1173 |
-
|
1174 |
|
1175 |
-
|
1176 |
-
|
1177 |
-
|
1178 |
-
|
1179 |
-
|
1180 |
-
|
1181 |
-
|
1182 |
-
|
1183 |
-
|
1184 |
-
|
1185 |
-
|
1186 |
-
|
1187 |
-
|
1188 |
-
|
1189 |
-
|
1190 |
-
|
1191 |
-
|
1192 |
-
|
1193 |
-
|
1194 |
-
|
1195 |
-
|
1196 |
-
|
1197 |
-
|
1198 |
-
|
1199 |
-
|
1200 |
-
|
1201 |
-
|
1202 |
-
|
1203 |
-
|
1204 |
-
|
1205 |
-
|
1206 |
-
|
1207 |
-
|
1208 |
-
|
1209 |
-
|
1210 |
-
|
1211 |
-
|
1212 |
-
|
1213 |
-
|
1214 |
-
|
1215 |
-
|
1216 |
-
|
1217 |
-
|
1218 |
-
|
1219 |
-
|
1220 |
-
|
1221 |
-
|
1222 |
-
|
1223 |
-
|
1224 |
-
|
1225 |
-
|
1226 |
-
|
1227 |
-
|
1228 |
-
|
1229 |
-
|
1230 |
-
|
1231 |
-
|
1232 |
-
|
1233 |
-
|
1234 |
-
|
1235 |
-
|
1236 |
-
|
1237 |
-
|
1238 |
-
|
1239 |
-
|
1240 |
-
|
1241 |
-
|
1242 |
-
|
1243 |
-
|
1244 |
-
|
1245 |
-
|
1246 |
-
|
1247 |
-
|
1248 |
-
|
1249 |
-
|
1250 |
-
|
1251 |
-
|
1252 |
-
|
1253 |
-
|
1254 |
-
|
1255 |
-
|
1256 |
-
|
1257 |
-
|
1258 |
-
|
1259 |
-
|
1260 |
-
|
1261 |
-
|
1262 |
-
|
1263 |
-
|
1264 |
-
|
1265 |
-
|
1266 |
-
|
1267 |
-
|
1268 |
-
|
1269 |
-
|
1270 |
-
|
1271 |
-
|
1272 |
-
|
1273 |
-
|
1274 |
-
|
1275 |
-
|
1276 |
-
|
1277 |
-
|
1278 |
-
|
1279 |
-
|
1280 |
-
|
1281 |
-
|
1282 |
-
|
1283 |
-
|
1284 |
-
|
1285 |
-
|
1286 |
-
|
1287 |
-
|
1288 |
-
|
1289 |
-
|
1290 |
-
|
1291 |
-
|
1292 |
-
|
1293 |
-
|
1294 |
-
|
1295 |
-
|
1296 |
-
|
1297 |
-
|
1298 |
-
|
1299 |
-
|
1300 |
-
|
1301 |
-
|
1302 |
-
|
1303 |
-
|
1304 |
-
|
1305 |
-
|
1306 |
-
|
1307 |
-
|
1308 |
-
|
1309 |
-
|
1310 |
-
|
1311 |
-
|
1312 |
-
|
1313 |
-
|
1314 |
-
|
1315 |
-
|
1316 |
-
|
1317 |
-
|
1318 |
-
|
1319 |
-
|
1320 |
-
|
1321 |
-
|
1322 |
-
|
1323 |
-
|
1324 |
-
|
1325 |
-
|
1326 |
-
|
1327 |
-
|
1328 |
-
|
1329 |
-
|
1330 |
-
|
1331 |
-
|
1332 |
-
|
1333 |
-
|
1334 |
-
|
1335 |
-
|
1336 |
-
|
1337 |
-
|
1338 |
-
|
1339 |
-
|
1340 |
-
|
1341 |
-
|
1342 |
-
|
1343 |
]
|
1344 |
|
1345 |
|
@@ -1353,4 +1358,4 @@ def format_metadata_for_prompt(core_name="news"):
|
|
1353 |
formatted_string += f" - **Type**: {field['type']}\n"
|
1354 |
formatted_string += f" - **Definition**: {field['definition']}\n"
|
1355 |
formatted_string += f" - **Examples**: {', '.join(map(str, field['example_values']))}\n\n"
|
1356 |
-
return formatted_string
|
|
|
161 |
"example_values": [50, 120.5, 176.157, 1000],
|
162 |
"definition": "The total value of a financial deal, in millions of USD. This is the primary numeric field for financial aggregations (sum, avg, etc.). To use this, you must also filter for news that has a deal value, e.g., 'total_deal_value_in_million:[0 TO *]'."
|
163 |
},
|
164 |
+
|
165 |
# NEW 'deal' CORE METADATA
|
166 |
{
|
167 |
"core_name": "deal",
|
|
|
370 |
"core_name": "compound",
|
371 |
"field_name": "molecule_id",
|
372 |
"type": "string",
|
373 |
+
# Placeholder, not in provided doc examples directly.
|
374 |
+
"example_values": ["mol_12345", "mol_67890"],
|
375 |
"definition": "Unique identifier for the molecule associated with the compound."
|
376 |
},
|
377 |
{
|
|
|
448 |
"core_name": "compound",
|
449 |
"field_name": "owner_company_name",
|
450 |
"type": "string (multi-valued, exact match, for faceting)",
|
451 |
+
# Placeholder, based on common patterns
|
452 |
+
"example_values": ["AstraZeneca Plc"],
|
453 |
"definition": "The canonical, standardized name(s) of the owner company of the compound. Use for faceting on owner companies."
|
454 |
},
|
455 |
{
|
|
|
498 |
"core_name": "compound",
|
499 |
"field_name": "mechanism",
|
500 |
"type": "string (multi-valued, specific, for faceting)",
|
501 |
+
# Placeholder
|
502 |
+
"example_values": ["Beta-1 Adrenergic Receptor Antagonist"],
|
503 |
"definition": "The specific mechanism of action of the compound. Use for very specific mechanism queries or faceting."
|
504 |
},
|
505 |
{
|
506 |
"core_name": "compound",
|
507 |
"field_name": "mechanism_s",
|
508 |
"type": "string (multi-valued, for searching)",
|
509 |
+
# Placeholder
|
510 |
+
"example_values": ["beta blocker", "adrenergic receptor antagonist"],
|
511 |
"definition": "Broader, multi-valued mechanisms of action and their synonyms. **Use this field for broad mechanism searches** in the `query` parameter."
|
512 |
},
|
513 |
{
|
|
|
611 |
{
|
612 |
"core_name": "compound",
|
613 |
"field_name": "is_orphan",
|
614 |
+
# Solr typically stores booleans as strings or numbers [14, 15, 21, 23]
|
615 |
+
"type": "string (boolean)",
|
616 |
"example_values": ["yes", "no"],
|
617 |
"definition": "Indicates if the compound has received orphan drug designation. Orphan drugs are intended for rare diseases that affect a small population, making them less profitable to develop without incentives. [2, 4, 7, 9, 10]"
|
618 |
},
|
|
|
645 |
"definition": "The logarithm of the octanol-water partition coefficient, a measure of a compound's lipophilicity (fat-liking) or hydrophilicity (water-liking). Higher values indicate more lipophilicity. [1, 3, 5, 6, 8]"
|
646 |
},
|
647 |
{
|
648 |
+
"core_name": "company",
|
649 |
+
"field_name": "US_state",
|
650 |
+
"type": "string",
|
651 |
+
"example_values": ["California", "Massachusetts", "New York"],
|
652 |
+
"definition": "The US state(s) where the company operates or has a significant presence."
|
653 |
+
},
|
654 |
+
{
|
655 |
+
"core_name": "company",
|
656 |
+
"field_name": "acquired_by",
|
657 |
+
"type": "string",
|
658 |
+
"example_values": ["Pfizer Inc.", "Johnson & Johnson"],
|
659 |
+
"definition": "Names of companies that have acquired this company."
|
660 |
+
},
|
661 |
+
{
|
662 |
+
"core_name": "company",
|
663 |
+
"field_name": "address",
|
664 |
+
"type": "string",
|
665 |
+
"example_values": ["123 Biotech Ave, Boston, MA 02110", "456 Pharma Rd, San Francisco, CA 94107"],
|
666 |
+
"definition": "Physical address(es) of the company."
|
667 |
+
},
|
668 |
+
{
|
669 |
+
"core_name": "company",
|
670 |
+
"field_name": "city",
|
671 |
+
"type": "string",
|
672 |
+
"example_values": ["Boston", "San Diego", "Basel"],
|
673 |
+
"definition": "City/cities where the company is located or has a significant presence."
|
674 |
+
},
|
675 |
+
{
|
676 |
+
"core_name": "company",
|
677 |
+
"field_name": "company_IPO_date",
|
678 |
+
"type": "string",
|
679 |
+
"example_values": ["2005-10-15", "2018-03-22"],
|
680 |
+
"definition": "Date(s) of the company's Initial Public Offering (IPO) in YYYY-MM-DD format."
|
681 |
+
},
|
682 |
+
{
|
683 |
+
"core_name": "company",
|
684 |
+
"field_name": "company_US_state",
|
685 |
+
"type": "string",
|
686 |
+
"example_values": ["California", "Massachusetts"],
|
687 |
+
"definition": "The primary US state of the company."
|
688 |
+
},
|
689 |
+
{
|
690 |
+
"core_name": "company",
|
691 |
+
"field_name": "company_business_model",
|
692 |
+
"type": "string",
|
693 |
+
"example_values": ["Drug Discovery", "Drug Development", "Contract Manufacturing", "Diagnostics"],
|
694 |
+
"definition": "Description(s) of the company's business model(s)."
|
695 |
+
},
|
696 |
+
{
|
697 |
+
"core_name": "company",
|
698 |
+
"field_name": "company_city",
|
699 |
+
"type": "string",
|
700 |
+
"example_values": ["Cambridge", "Princeton"],
|
701 |
+
"definition": "The primary city of the company."
|
702 |
+
},
|
703 |
+
{
|
704 |
+
"core_name": "company",
|
705 |
+
"field_name": "company_development_capabilities",
|
706 |
+
"type": "string",
|
707 |
+
"example_values": ["Preclinical Research", "Clinical Trials Management", "CMC Development", "Regulatory Affairs"],
|
708 |
+
"definition": "Capabilities of the company in drug/product development."
|
709 |
+
},
|
710 |
+
{
|
711 |
+
"core_name": "company",
|
712 |
+
"field_name": "company_gross_profit",
|
713 |
+
"type": "float",
|
714 |
+
"example_values": [1500.5, 750.25],
|
715 |
+
"definition": "Gross profit(s) of the company, possibly over different periods (in millions USD)."
|
716 |
+
},
|
717 |
+
{
|
718 |
+
"core_name": "company",
|
719 |
+
"field_name": "company_highest_phase",
|
720 |
+
"type": "string",
|
721 |
+
"example_values": ["Marketed", "Phase 3", "Preclinical"],
|
722 |
+
"definition": "The highest development phase achieved by any of the company's products/molecules."
|
723 |
+
},
|
724 |
+
{
|
725 |
+
"core_name": "company",
|
726 |
+
"field_name": "company_is_active",
|
727 |
+
"type": "string",
|
728 |
+
"example_values": ["Yes", "No"],
|
729 |
+
"definition": "Indicates if the company is currently active ('Yes' or 'No')."
|
730 |
+
},
|
731 |
+
{
|
732 |
+
"core_name": "company",
|
733 |
+
"field_name": "company_liabilities",
|
734 |
+
"type": "float",
|
735 |
+
"example_values": [800.75, 400.0],
|
736 |
+
"definition": "Total liabilities of the company, possibly over different periods (in millions USD)."
|
737 |
+
},
|
738 |
+
{
|
739 |
+
"core_name": "company",
|
740 |
+
"field_name": "company_location_facility_type",
|
741 |
+
"type": "string",
|
742 |
+
"example_values": ["R&D Center", "Manufacturing Plant", "Headquarters", "Clinical Site"],
|
743 |
+
"definition": "Type of facilities associated with the company's locations (e.g., 'manufacturing', 'R&D')."
|
744 |
+
},
|
745 |
+
{
|
746 |
+
"core_name": "company",
|
747 |
+
"field_name": "company_main_territory",
|
748 |
+
"type": "text_ci",
|
749 |
+
"example_values": ["North America", "Europe", "Asia-Pacific"],
|
750 |
+
"definition": "Main geographical territories where the company operates or focuses."
|
751 |
+
},
|
752 |
+
{
|
753 |
+
"core_name": "company",
|
754 |
+
"field_name": "company_market_cap",
|
755 |
+
"type": "float",
|
756 |
+
"example_values": [50000.0, 12500.75],
|
757 |
+
"definition": "The market capitalization of the company (in millions USD)."
|
758 |
+
},
|
759 |
+
{
|
760 |
+
"core_name": "company",
|
761 |
+
"field_name": "company_name",
|
762 |
+
"type": "string",
|
763 |
+
"example_values": ["BioGen Innovations", "TheraWorks Pharmaceuticals", "MediTech Solutions"],
|
764 |
+
"definition": "The official name of the company."
|
765 |
+
},
|
766 |
+
{
|
767 |
+
"core_name": "company",
|
768 |
+
"field_name": "company_net_income",
|
769 |
+
"type": "float",
|
770 |
+
"example_values": [250.1, -50.0],
|
771 |
+
"definition": "Net income(s) of the company, possibly over different periods (in millions USD)."
|
772 |
+
},
|
773 |
+
{
|
774 |
+
"core_name": "company",
|
775 |
+
"field_name": "company_number_of_employees",
|
776 |
+
"type": "int",
|
777 |
+
"example_values": [500, 12000, 75],
|
778 |
+
"definition": "Number of employees in the company, possibly over different periods."
|
779 |
+
},
|
780 |
+
{
|
781 |
+
"core_name": "company",
|
782 |
+
"field_name": "company_operating_income",
|
783 |
+
"type": "float",
|
784 |
+
"example_values": [300.0, 80.5],
|
785 |
+
"definition": "Operating income(s) of the company, possibly over different periods (in millions USD)."
|
786 |
+
},
|
787 |
+
{
|
788 |
+
"core_name": "company",
|
789 |
+
"field_name": "company_private_public",
|
790 |
+
"type": "string",
|
791 |
+
"example_values": ["Public", "Private"],
|
792 |
+
"definition": "Indicates if the company is 'Private' or 'Public'."
|
793 |
+
},
|
794 |
+
{
|
795 |
+
"core_name": "company",
|
796 |
+
"field_name": "company_r_d",
|
797 |
+
"type": "float",
|
798 |
+
"example_values": [120.0, 45.7],
|
799 |
+
"definition": "Research and Development (R&D) expenditure of the company, possibly over different periods (in millions USD)."
|
800 |
+
},
|
801 |
+
{
|
802 |
+
"core_name": "company",
|
803 |
+
"field_name": "company_revenue",
|
804 |
+
"type": "float",
|
805 |
+
"example_values": [2500.0, 1100.2],
|
806 |
+
"definition": "Total revenue(s) of the company, possibly over different periods (in millions USD)."
|
807 |
+
},
|
808 |
+
{
|
809 |
+
"core_name": "company",
|
810 |
+
"field_name": "company_role",
|
811 |
+
"type": "string",
|
812 |
+
"example_values": ["Developer", "Manufacturer", "Distributor", "Contract Research Organization (CRO)"],
|
813 |
+
"definition": "Role(s) of the company (e.g., 'developer', 'manufacturer')."
|
814 |
+
},
|
815 |
+
{
|
816 |
+
"core_name": "company",
|
817 |
+
"field_name": "company_sales",
|
818 |
+
"type": "float",
|
819 |
+
"example_values": [2300.0, 950.0],
|
820 |
+
"definition": "Sales figures of the company, possibly over different periods (in millions USD)."
|
821 |
+
},
|
822 |
+
{
|
823 |
+
"core_name": "company",
|
824 |
+
"field_name": "company_sales_ga_expenses",
|
825 |
+
"type": "float",
|
826 |
+
"example_values": [500.0, 210.5],
|
827 |
+
"definition": "Sales, General, and Administrative (SG&A) expenses of the company (in millions USD)."
|
828 |
+
},
|
829 |
+
{
|
830 |
+
"core_name": "company",
|
831 |
+
"field_name": "company_summary",
|
832 |
+
"type": "string",
|
833 |
+
"example_values": ["A leading biotechnology company focused on oncology.", "Specializes in developing advanced drug delivery systems."],
|
834 |
+
"definition": "A summary or description of the company."
|
835 |
+
},
|
836 |
+
{
|
837 |
+
"core_name": "company",
|
838 |
+
"field_name": "company_synonym",
|
839 |
+
"type": "string",
|
840 |
+
"example_values": ["BioGen Inc.", "TheraWorks Pharma"],
|
841 |
+
"definition": "Alternative names or synonyms for the company."
|
842 |
+
},
|
843 |
+
{
|
844 |
+
"core_name": "company",
|
845 |
+
"field_name": "company_territory",
|
846 |
+
"type": "text_ci",
|
847 |
+
"example_values": ["United States", "Germany", "Japan", "Global"],
|
848 |
+
"definition": "Geographical territories where the company operates."
|
849 |
+
},
|
850 |
+
{
|
851 |
+
"core_name": "company",
|
852 |
+
"field_name": "company_territory_hierarchy",
|
853 |
+
"type": "hierarchy",
|
854 |
+
"example_values": ["continent/North America/country/United States", "continent/Europe/country/Germany"],
|
855 |
+
"definition": "Hierarchical representation of the company's operating territories."
|
856 |
+
},
|
857 |
+
{
|
858 |
+
"core_name": "company",
|
859 |
+
"field_name": "company_territory_s",
|
860 |
+
"type": "string",
|
861 |
+
"example_values": ["United States", "Germany", "Japan"],
|
862 |
+
"definition": "String representation of the company's operating territories (likely for faceted search)."
|
863 |
+
},
|
864 |
+
{
|
865 |
+
"core_name": "company",
|
866 |
+
"field_name": "company_total_assets",
|
867 |
+
"type": "float",
|
868 |
+
"example_values": [3000.0, 1500.0],
|
869 |
+
"definition": "Total assets of the company, possibly over different periods (in millions USD)."
|
870 |
+
},
|
871 |
+
{
|
872 |
+
"core_name": "company",
|
873 |
+
"field_name": "company_total_current_assets",
|
874 |
+
"type": "float",
|
875 |
+
"example_values": [1200.0, 600.0],
|
876 |
+
"definition": "Total current assets of the company, possibly over different periods (in millions USD)."
|
877 |
+
},
|
878 |
+
{
|
879 |
+
"core_name": "company",
|
880 |
+
"field_name": "company_total_current_liabilities",
|
881 |
+
"type": "float",
|
882 |
+
"example_values": [400.0, 200.0],
|
883 |
+
"definition": "Total current liabilities of the company, possibly over different periods (in millions USD)."
|
884 |
+
},
|
885 |
+
{
|
886 |
+
"core_name": "company",
|
887 |
+
"field_name": "company_total_equity",
|
888 |
+
"type": "float",
|
889 |
+
"example_values": [2600.0, 1300.0],
|
890 |
+
"definition": "Total equity of the company, possibly over different periods (in millions USD)."
|
891 |
+
},
|
892 |
+
{
|
893 |
+
"core_name": "company",
|
894 |
+
"field_name": "company_website",
|
895 |
+
"type": "string",
|
896 |
+
"example_values": ["https://www.biogeninnovations.com", "https://www.theraworks.com"],
|
897 |
+
"definition": "The official website URL of the company."
|
898 |
+
},
|
899 |
+
{
|
900 |
+
"core_name": "company",
|
901 |
+
"field_name": "company_year_founded",
|
902 |
+
"type": "string",
|
903 |
+
"example_values": ["1998", "2010"],
|
904 |
+
"definition": "The year the company was founded."
|
905 |
+
},
|
906 |
+
{
|
907 |
+
"core_name": "company",
|
908 |
+
"field_name": "conjugate_molecule_type_1",
|
909 |
+
"type": "text_ci",
|
910 |
+
"example_values": ["Antibody", "Polymer"],
|
911 |
+
"definition": "Type of the first conjugate molecule associated with the company's products."
|
912 |
+
},
|
913 |
+
{
|
914 |
+
"core_name": "company",
|
915 |
+
"field_name": "conjugate_molecule_type_2",
|
916 |
+
"type": "text_ci",
|
917 |
+
"example_values": ["Small Molecule", "Peptide"],
|
918 |
+
"definition": "Type of the second conjugate molecule associated with the company's products."
|
919 |
+
},
|
920 |
+
{
|
921 |
+
"core_name": "company",
|
922 |
+
"field_name": "conjugate_molecule_types",
|
923 |
+
"type": "text_ci",
|
924 |
+
"example_values": ["Antibody-Drug Conjugate", "Polymer-Drug Conjugate"],
|
925 |
+
"definition": "Overall types of conjugate molecules associated with the company's products."
|
926 |
+
},
|
927 |
+
{
|
928 |
+
"core_name": "company",
|
929 |
+
"field_name": "corporate_history",
|
930 |
+
"type": "string",
|
931 |
+
"example_values": ["Founded in 1998, went public in 2005.", "Acquired by Pfizer in 2020."],
|
932 |
+
"definition": "Historical information about the company's corporate activities."
|
933 |
+
},
|
934 |
+
{
|
935 |
+
"core_name": "company",
|
936 |
+
"field_name": "cp_moment_updated",
|
937 |
+
"type": "string",
|
938 |
+
"example_values": ["2023-01-15T10:30:00Z", "2024-05-20T14:00:00Z"],
|
939 |
+
"definition": "Timestamp(s) when the company's profile was last updated in ISO 8601 format."
|
940 |
+
},
|
941 |
+
{
|
942 |
+
"core_name": "company",
|
943 |
+
"field_name": "drug_delivery_branch",
|
944 |
+
"type": "string",
|
945 |
+
"example_values": ["Oral Delivery", "Injectable Delivery", "Transdermal Patches"],
|
946 |
+
"definition": "Branch(es) of drug delivery technologies related to the company's products."
|
947 |
+
},
|
948 |
+
{
|
949 |
+
"core_name": "company",
|
950 |
+
"field_name": "drug_delivery_branch_hierarchy",
|
951 |
+
"type": "hierarchy",
|
952 |
+
"example_values": ["route/Oral/branch/Oral Delivery", "route/Parenteral/branch/Injectable Delivery"],
|
953 |
+
"definition": "Hierarchical representation of drug delivery branches."
|
954 |
+
},
|
955 |
+
{
|
956 |
+
"core_name": "company",
|
957 |
+
"field_name": "drug_delivery_branch_s",
|
958 |
+
"type": "string",
|
959 |
+
"example_values": ["Oral Delivery", "Injectable Delivery"],
|
960 |
+
"definition": "String representation of drug delivery branches (likely for faceted search)."
|
961 |
+
},
|
962 |
+
{
|
963 |
+
"core_name": "company",
|
964 |
+
"field_name": "drug_delivery_technology",
|
965 |
+
"type": "string",
|
966 |
+
"example_values": ["Nanoparticle Delivery", "Liposomal Encapsulation", "Microneedle Systems"],
|
967 |
+
"definition": "Specific drug delivery technologies used by the company."
|
968 |
+
},
|
969 |
+
{
|
970 |
+
"core_name": "company",
|
971 |
+
"field_name": "drug_delivery_technology_categories",
|
972 |
+
"type": "string",
|
973 |
+
"example_values": ["Advanced Formulations", "Targeted Delivery"],
|
974 |
+
"definition": "Categories of drug delivery technologies."
|
975 |
+
},
|
976 |
+
{
|
977 |
+
"core_name": "company",
|
978 |
+
"field_name": "drug_delivery_technology_hierarchy",
|
979 |
+
"type": "hierarchy",
|
980 |
+
"example_values": ["category/Advanced Formulations/technology/Nanoparticle Delivery"],
|
981 |
+
"definition": "Hierarchical representation of drug delivery technologies."
|
982 |
+
},
|
983 |
+
{
|
984 |
+
"core_name": "company",
|
985 |
+
"field_name": "drug_delivery_technology_names",
|
986 |
+
"type": "string",
|
987 |
+
"example_values": ["NanoCaps", "LipoSphere", "MicroDerm"],
|
988 |
+
"definition": "Names of drug delivery technologies."
|
989 |
+
},
|
990 |
+
{
|
991 |
+
"core_name": "company",
|
992 |
+
"field_name": "drug_delivery_technology_s",
|
993 |
+
"type": "string",
|
994 |
+
"example_values": ["nanoparticle", "liposomal", "microneedle"],
|
995 |
+
"definition": "String representation of drug delivery technologies (likely for faceted search)."
|
996 |
+
},
|
997 |
+
{
|
998 |
+
"core_name": "company",
|
999 |
+
"field_name": "efficiency_income_employee",
|
1000 |
+
"type": "float",
|
1001 |
+
"example_values": [50000.0, 75000.0],
|
1002 |
+
"definition": "Efficiency metric: income per employee (in USD)."
|
1003 |
+
},
|
1004 |
+
{
|
1005 |
+
"core_name": "company",
|
1006 |
+
"field_name": "efficiency_revenue_employee",
|
1007 |
+
"type": "float",
|
1008 |
+
"example_values": [250000.0, 180000.0],
|
1009 |
+
"definition": "Efficiency metric: revenue per employee (in USD)."
|
1010 |
+
},
|
1011 |
+
{
|
1012 |
+
"core_name": "company",
|
1013 |
+
"field_name": "efficiency_total_asset_turnover",
|
1014 |
+
"type": "float",
|
1015 |
+
"example_values": [0.8, 1.2],
|
1016 |
+
"definition": "Efficiency metric: total asset turnover."
|
1017 |
+
},
|
1018 |
+
{
|
1019 |
+
"core_name": "company",
|
1020 |
+
"field_name": "email",
|
1021 |
+
"type": "string",
|
1022 |
+
"example_values": ["[email protected]", "[email protected]"],
|
1023 |
+
"definition": "Email address(es) for the company."
|
1024 |
+
},
|
1025 |
+
{
|
1026 |
+
"core_name": "company",
|
1027 |
+
"field_name": "facility_state",
|
1028 |
+
"type": "string",
|
1029 |
+
"example_values": ["Maryland", "North Carolina"],
|
1030 |
+
"definition": "State(s) where company facilities are located."
|
1031 |
+
},
|
1032 |
+
{
|
1033 |
+
"core_name": "company",
|
1034 |
+
"field_name": "facility_territory",
|
1035 |
+
"type": "text_ci",
|
1036 |
+
"example_values": ["United States", "Ireland"],
|
1037 |
+
"definition": "Geographical territories where company facilities are located."
|
1038 |
+
},
|
1039 |
+
{
|
1040 |
+
"core_name": "company",
|
1041 |
+
"field_name": "facility_territory_id",
|
1042 |
+
"type": "text_ci",
|
1043 |
+
"example_values": ["USA", "IRL"],
|
1044 |
+
"definition": "ID(s) for the geographical territories of company facilities."
|
1045 |
+
},
|
1046 |
+
{
|
1047 |
+
"core_name": "company",
|
1048 |
+
"field_name": "fax",
|
1049 |
+
"type": "string",
|
1050 |
+
"example_values": ["+1-123-456-7890", "+44-20-1234-5678"],
|
1051 |
+
"definition": "Fax number(s) for the company."
|
1052 |
+
},
|
1053 |
+
{
|
1054 |
+
"core_name": "company",
|
1055 |
+
"field_name": "founder",
|
1056 |
+
"type": "string",
|
1057 |
+
"example_values": ["Dr. Jane Doe", "John Smith"],
|
1058 |
+
"definition": "The founder(s) of the company."
|
1059 |
+
},
|
1060 |
+
{
|
1061 |
+
"core_name": "company",
|
1062 |
+
"field_name": "generic_or_innovator",
|
1063 |
+
"type": "string",
|
1064 |
+
"example_values": ["Innovator", "Generic"],
|
1065 |
+
"definition": "Indicates if the company primarily develops 'Generic' or 'Innovator' products."
|
1066 |
+
},
|
1067 |
+
{
|
1068 |
+
"core_name": "company",
|
1069 |
+
"field_name": "highest_phase",
|
1070 |
+
"type": "string",
|
1071 |
+
"example_values": ["Marketed", "Phase 3"],
|
1072 |
+
"definition": "The highest development phase achieved by any of the company's products/molecules."
|
1073 |
+
},
|
1074 |
+
{
|
1075 |
+
"core_name": "company",
|
1076 |
+
"field_name": "id",
|
1077 |
+
"type": "string",
|
1078 |
+
"example_values": ["COMP_0001", "COMP_0002", "COMP_0003"],
|
1079 |
+
"definition": "Unique identifier for the company."
|
1080 |
+
},
|
1081 |
+
{
|
1082 |
+
"core_name": "company",
|
1083 |
+
"field_name": "investor_company",
|
1084 |
+
"type": "string",
|
1085 |
+
"example_values": ["BlackRock", "Sequoia Capital"],
|
1086 |
+
"definition": "Names of companies that have invested in this company."
|
1087 |
+
},
|
1088 |
+
{
|
1089 |
+
"core_name": "company",
|
1090 |
+
"field_name": "investors",
|
1091 |
+
"type": "string",
|
1092 |
+
"example_values": ["VentureCorp Capital", "Angel Investors Network"],
|
1093 |
+
"definition": "Names of individual or institutional investors in the company."
|
1094 |
+
},
|
1095 |
+
{
|
1096 |
+
"core_name": "company",
|
1097 |
+
"field_name": "last_update_time",
|
1098 |
+
"type": "date",
|
1099 |
+
"example_values": ["2023-11-01T08:00:00Z", "2024-01-25T16:45:00Z"],
|
1100 |
+
"definition": "Timestamp(s) of the last update to the company's record in ISO 8601 format."
|
1101 |
+
},
|
1102 |
+
{
|
1103 |
+
"core_name": "company",
|
1104 |
+
"field_name": "last_update_user",
|
1105 |
+
"type": "string",
|
1106 |
+
"example_values": ["admin_user_1", "data_editor_2"],
|
1107 |
+
"definition": "User(s) who last updated the company's record."
|
1108 |
+
},
|
1109 |
+
{
|
1110 |
+
"core_name": "company",
|
1111 |
+
"field_name": "liquidity_data_current_ratio_mrq",
|
1112 |
+
"type": "float",
|
1113 |
+
"example_values": [1.8, 2.5],
|
1114 |
+
"definition": "Liquidity data: current ratio for the most recent quarter (MRQ)."
|
1115 |
+
},
|
1116 |
+
{
|
1117 |
+
"core_name": "company",
|
1118 |
+
"field_name": "liquidity_data_current_ratio_yoy",
|
1119 |
+
"type": "float",
|
1120 |
+
"example_values": [1.9, 2.3],
|
1121 |
+
"definition": "Liquidity data: current ratio year-over-year (YOY)."
|
1122 |
+
},
|
1123 |
+
{
|
1124 |
+
"core_name": "company",
|
1125 |
+
"field_name": "liquidity_data_quick_ratio_mrq",
|
1126 |
+
"type": "float",
|
1127 |
+
"example_values": [1.2, 1.7],
|
1128 |
+
"definition": "Liquidity data: quick ratio for the most recent quarter (MRQ)."
|
1129 |
+
},
|
1130 |
+
{
|
1131 |
+
"core_name": "company",
|
1132 |
+
"field_name": "liquidity_data_quick_ratio_yoy",
|
1133 |
+
"type": "float",
|
1134 |
+
"example_values": [1.3, 1.6],
|
1135 |
+
"definition": "Liquidity data: quick ratio year-over-year (YOY)."
|
1136 |
+
},
|
1137 |
+
{
|
1138 |
+
"core_name": "company",
|
1139 |
+
"field_name": "major_business_model",
|
1140 |
+
"type": "string",
|
1141 |
+
"example_values": ["Biopharmaceutical Development", "Medical Device Manufacturing"],
|
1142 |
+
"definition": "Major business model(s) of the company."
|
1143 |
+
},
|
1144 |
+
{
|
1145 |
+
"core_name": "company",
|
1146 |
+
"field_name": "marketing_status",
|
1147 |
+
"type": "text_ci",
|
1148 |
+
"example_values": ["Marketed", "Pre-Market", "Discontinued"],
|
1149 |
+
"definition": "Current marketing status of the company's products (e.g., 'pre-market', 'on-market')."
|
1150 |
+
},
|
1151 |
+
{
|
1152 |
+
"core_name": "company",
|
1153 |
+
"field_name": "mechanism_type",
|
1154 |
+
"type": "string",
|
1155 |
+
"example_values": ["Kinase Inhibitor", "Monoclonal Antibody", "Gene Therapy"],
|
1156 |
+
"definition": "Mechanism of action type(s) for molecules/products associated with the company."
|
1157 |
+
},
|
1158 |
+
{
|
1159 |
+
"core_name": "company",
|
1160 |
+
"field_name": "mechanism_type_hierarchy",
|
1161 |
+
"type": "hierarchy",
|
1162 |
+
"example_values": ["type/Kinase Inhibitor", "type/Monoclonal Antibody"],
|
1163 |
+
"definition": "Hierarchical representation of mechanism types."
|
1164 |
+
},
|
1165 |
+
{
|
1166 |
+
"core_name": "company",
|
1167 |
+
"field_name": "molecule_api_group",
|
1168 |
+
"type": "string",
|
1169 |
+
"example_values": ["Small Molecules", "Biologics", "Gene Therapies"],
|
1170 |
+
"definition": "API (Active Pharmaceutical Ingredient) group(s) of molecules associated with the company."
|
1171 |
+
},
|
1172 |
+
{
|
1173 |
+
"core_name": "company",
|
1174 |
+
"field_name": "molecule_name",
|
1175 |
+
"type": "string",
|
1176 |
+
"example_values": ["DrugX-200", "mAb-Y101", "GeneEdit-Z"],
|
1177 |
+
"definition": "Names of molecules associated with the company."
|
1178 |
+
},
|
1179 |
|
1180 |
+
{
|
1181 |
+
"core_name": "company",
|
1182 |
+
"field_name": "molecule_type",
|
1183 |
+
"type": "string",
|
1184 |
+
"example_values": ["Small Molecule", "Monoclonal Antibody", "CRISPR-Cas9"],
|
1185 |
+
"definition": "Type(s) of molecules associated with the company."
|
1186 |
+
},
|
1187 |
+
{
|
1188 |
+
"core_name": "company",
|
1189 |
+
"field_name": "original_financial_rd",
|
1190 |
+
"type": "string",
|
1191 |
+
"example_values": ["$120,000,000", "€45M"],
|
1192 |
+
"definition": "Original raw R&D financial data (as string)."
|
1193 |
+
},
|
1194 |
+
{
|
1195 |
+
"core_name": "company",
|
1196 |
+
"field_name": "original_financial_total_revenue",
|
1197 |
+
"type": "string",
|
1198 |
+
"example_values": ["$2.5 Billion", "£1.1B"],
|
1199 |
+
"definition": "Original raw total revenue financial data (as string)."
|
1200 |
+
},
|
1201 |
+
{
|
1202 |
+
"core_name": "company",
|
1203 |
+
"field_name": "owner_company_private_public",
|
1204 |
+
"type": "string",
|
1205 |
+
"example_values": ["Public", "Private"],
|
1206 |
+
"definition": "Indicates if the owner company is 'Private' or 'Public'."
|
1207 |
+
},
|
1208 |
+
{
|
1209 |
+
"core_name": "company",
|
1210 |
+
"field_name": "phase",
|
1211 |
+
"type": "string",
|
1212 |
+
"example_values": ["Phase 1", "Phase 2", "Preclinical", "Marketed"],
|
1213 |
+
"definition": "Development phase(s) of products/molecules associated with the company."
|
1214 |
+
},
|
1215 |
+
{
|
1216 |
+
"core_name": "company",
|
1217 |
+
"field_name": "product_name",
|
1218 |
+
"type": "string",
|
1219 |
+
"example_values": ["OncoTherapy-A", "CardioGuard-XL", "NeuroBoost-System"],
|
1220 |
+
"definition": "Names of products developed or marketed by the company."
|
1221 |
+
},
|
1222 |
+
{
|
1223 |
+
"core_name": "company",
|
1224 |
+
"field_name": "product_synonym",
|
1225 |
+
"type": "string",
|
1226 |
+
"example_values": ["OncoTA", "CGXL"],
|
1227 |
+
"definition": "Synonyms for products associated with the company."
|
1228 |
+
},
|
1229 |
+
{
|
1230 |
+
"core_name": "company",
|
1231 |
+
"field_name": "profitability_data_operating_margin_ttm",
|
1232 |
+
"type": "float",
|
1233 |
+
"example_values": [0.15, 0.22],
|
1234 |
+
"definition": "Profitability data: operating margin for the trailing twelve months (TTM)."
|
1235 |
+
},
|
1236 |
+
{
|
1237 |
+
"core_name": "company",
|
1238 |
+
"field_name": "profitability_data_profit_margin",
|
1239 |
+
"type": "float",
|
1240 |
+
"example_values": [0.10, 0.18],
|
1241 |
+
"definition": "Profitability data: overall profit margin."
|
1242 |
+
},
|
1243 |
+
{
|
1244 |
+
"core_name": "company",
|
1245 |
+
"field_name": "profitability_data_return_on_assets_ttm",
|
1246 |
+
"type": "float",
|
1247 |
+
"example_values": [0.08, 0.14],
|
1248 |
+
"definition": "Profitability data: return on assets for the trailing twelve months (TTM)."
|
1249 |
+
},
|
1250 |
+
{
|
1251 |
+
"core_name": "company",
|
1252 |
+
"field_name": "profitability_data_return_on_equity_ttm",
|
1253 |
+
"type": "float",
|
1254 |
+
"example_values": [0.12, 0.20],
|
1255 |
+
"definition": "Profitability data: return on equity for the trailing twelve months (TTM)."
|
1256 |
+
},
|
1257 |
+
{
|
1258 |
+
"core_name": "company",
|
1259 |
+
"field_name": "route",
|
1260 |
+
"type": "string",
|
1261 |
+
"example_values": ["Oral", "Intravenous", "Topical"],
|
1262 |
+
"definition": "Route(s) of administration for products/molecules associated with the company."
|
1263 |
+
},
|
1264 |
+
{
|
1265 |
+
"core_name": "company",
|
1266 |
+
"field_name": "route_branch",
|
1267 |
+
"type": "string",
|
1268 |
+
"example_values": ["Oral Solid Dosage", "Injectable Solutions"],
|
1269 |
+
"definition": "Branch(es) of route of administration."
|
1270 |
+
},
|
1271 |
+
{
|
1272 |
+
"core_name": "company",
|
1273 |
+
"field_name": "route_branch_hierarchy",
|
1274 |
+
"type": "hierarchy",
|
1275 |
+
"example_values": ["route/Oral/branch/Oral Solid Dosage"],
|
1276 |
+
"definition": "Hierarchical representation of route of administration branches."
|
1277 |
+
},
|
1278 |
+
{
|
1279 |
+
"core_name": "company",
|
1280 |
+
"field_name": "route_branch_s",
|
1281 |
+
"type": "string",
|
1282 |
+
"example_values": ["Oral Solid Dosage", "Injectable Solutions"],
|
1283 |
+
"definition": "String representation of route of administration branches (likely for faceted search)."
|
1284 |
+
},
|
1285 |
+
{
|
1286 |
+
"core_name": "company",
|
1287 |
+
"field_name": "route_s",
|
1288 |
+
"type": "text_ci",
|
1289 |
+
"example_values": ["oral", "injection", "topical"],
|
1290 |
+
"definition": "String representation of routes of administration (likely for faceted search)."
|
1291 |
+
},
|
1292 |
+
{
|
1293 |
+
"core_name": "company",
|
1294 |
+
"field_name": "subsidiary",
|
1295 |
+
"type": "string",
|
1296 |
+
"example_values": ["BioGen Labs", "TheraWorks Diagnostics"],
|
1297 |
+
"definition": "Names of subsidiaries of this company."
|
1298 |
+
},
|
1299 |
+
{
|
1300 |
+
"core_name": "company",
|
1301 |
+
"field_name": "subsidiary_of_company",
|
1302 |
+
"type": "string",
|
1303 |
+
"example_values": ["Global Pharma Corp", "United Healthcare Inc."],
|
1304 |
+
"definition": "Names of parent companies if this company is a subsidiary."
|
1305 |
+
},
|
1306 |
+
{
|
1307 |
+
"core_name": "company",
|
1308 |
+
"field_name": "telephone",
|
1309 |
+
"type": "string",
|
1310 |
+
"example_values": ["+1-555-123-4567", "+49-30-9876-5432"],
|
1311 |
+
"definition": "Telephone number(s) for the company."
|
1312 |
+
},
|
1313 |
+
{
|
1314 |
+
"core_name": "company",
|
1315 |
+
"field_name": "therapeutic_category",
|
1316 |
+
"type": "string",
|
1317 |
+
"example_values": ["Oncology", "Cardiology", "Neurology"],
|
1318 |
+
"definition": "Therapeutic category/categories of products/molecules associated with the company."
|
1319 |
+
},
|
1320 |
+
{
|
1321 |
+
"core_name": "company",
|
1322 |
+
"field_name": "therapeutic_category_hierarchy",
|
1323 |
+
"type": "hierarchy",
|
1324 |
+
"example_values": ["disease/Cancer/category/Oncology", "disease/Cardiovascular/category/Cardiology"],
|
1325 |
+
"definition": "Hierarchical representation of therapeutic categories."
|
1326 |
+
},
|
1327 |
+
{
|
1328 |
+
"core_name": "company",
|
1329 |
+
"field_name": "therapeutic_category_s",
|
1330 |
+
"type": "text_ci",
|
1331 |
+
"example_values": ["cancer", "heart disease", "nervous system disorders"],
|
1332 |
+
"definition": "String representation of therapeutic categories (likely for faceted search)."
|
1333 |
+
},
|
1334 |
+
{
|
1335 |
+
"core_name": "company",
|
1336 |
+
"field_name": "therapeutic_group_id",
|
1337 |
+
"type": "string",
|
1338 |
+
"example_values": ["THERA_ONC_01", "THERA_CARD_02"],
|
1339 |
+
"definition": "ID(s) for the therapeutic group(s) of products/molecules associated with the company."
|
1340 |
+
},
|
1341 |
+
{
|
1342 |
+
"core_name": "company",
|
1343 |
+
"field_name": "type",
|
1344 |
+
"type": "string",
|
1345 |
+
"example_values": ["Biotech", "Pharmaceutical", "CRO", "Medical Device Company"],
|
1346 |
+
"definition": "Type(s) of the company (e.g., 'Biotech', 'Pharma')."
|
1347 |
+
}
|
1348 |
]
|
1349 |
|
1350 |
|
|
|
1358 |
formatted_string += f" - **Type**: {field['type']}\n"
|
1359 |
formatted_string += f" - **Definition**: {field['definition']}\n"
|
1360 |
formatted_string += f" - **Examples**: {', '.join(map(str, field['example_values']))}\n\n"
|
1361 |
+
return formatted_string
|